Imatinib is such a drug that inhibits oncogenic tyrosine kinases c-Abl and c-kit used in the treatment of chronic leukemias and gastrointestinal stromal tumors respectively5,6. This evidence concerns the gene KIT and gastrointestinal stromal tumor.